Study of the Absorption, Metabolism, and Excretion Following a Single Dose of [14C]-Poziotinib in Healthy Male Subjects
Clinical trial NCT04436562 · COMPLETED
Trial details
- NCT number
- NCT04436562
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2020-07-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.